IMpower133: Real-World vs Clinical Trial Data in SCLC
(MedPage Today) -- At the virtual European Society for Medical Oncology (ESMO) meeting, researchers explored the clinical characteristics, treatment patterns, and early outcomes of the addition of atezolizumab (Tecentriq) to chemotherapy in small...
Read more »